ID SK-MEL-30 AC CVCL_0039 SY SK-Mel-30; SK Mel 30; SKMEL-30; Sk Mel30; SKMEL30; AW-Mel DR BTO; BTO_0002133 DR CLO; CLO_0009045 DR EFO; EFO_0006488 DR CLDB; cl4323 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-2706 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR BioGRID_ORCS_Cell_line; 465 DR BioSample; SAMN03473251 DR BioSample; SAMN10988313 DR cancercelllines; CVCL_0039 DR Cell_Model_Passport; SIDM00392 DR ChEMBL-Cells; CHEMBL3308128 DR ChEMBL-Targets; CHEMBL1075577 DR Cosmic; 706090 DR Cosmic; 721825 DR Cosmic; 851035 DR Cosmic; 888061 DR Cosmic; 888834 DR Cosmic; 909726 DR Cosmic; 933128 DR Cosmic; 1022283 DR Cosmic; 1060425 DR Cosmic; 1669146 DR Cosmic-CLP; 909726 DR DepMap; ACH-000810 DR DSMZ; ACC-151 DR DSMZCellDive; ACC-151 DR EGA; EGAS00001000610 DR EGA; EGAS00001000978 DR EGA; EGAS00001002554 DR GDSC; 909726 DR GEO; GSM784510 DR GEO; GSM887586 DR GEO; GSM888669 DR GEO; GSM1670441 DR GEO; GSM7701406 DR GEO; GSM7701407 DR IARC_TP53; 27239 DR LiGeA; CCLE_671 DR LINCS_LDP; LCL-1257 DR PharmacoDB; SKMEL30_1398_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_0039 DR PubChem_Cell_line; CVCL_0039 DR Wikidata; Q54954059 RX DOI=10.1007/978-1-4615-7228-2_39; RX PubMed=978138; RX PubMed=1067619; RX PubMed=1716514; RX PubMed=3081645; RX PubMed=3473501; RX PubMed=3518877; RX PubMed=6864164; RX PubMed=6933476; RX PubMed=7175440; RX PubMed=7509835; RX PubMed=9598804; RX PubMed=10766161; RX PubMed=11668190; RX PubMed=15009714; RX PubMed=16957166; RX PubMed=20164919; RX PubMed=21725359; RX PubMed=22460905; RX PubMed=24576830; RX PubMed=25485619; RX PubMed=25877200; RX PubMed=26589293; RX PubMed=27397505; RX PubMed=30629668; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31978347; RX PubMed=35839778; WW Info; HPA; -; https://www.proteinatlas.org/learn/cellines WW Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-30-human-melanoma-cell-line CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Part of: Human Protein Atlas, Cell Atlas panel. CC From: Memorial Sloan Kettering Cancer Center; New York; USA. CC Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-526. CC Population: Caucasian. CC Characteristics: Pigmented. CC Doubling time: ~30 hours (DSMZ=ACC-151). CC HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:06 (PubMed=26589293). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804). CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly1339Arg (c.4015G>C); ClinVar=VCV000233611; Zygosity=Heterozygous (Cosmic-CLP=909726; DepMap=ACH-000810). CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1406Ter (c.4216C>T); ClinVar=VCV000142519; Zygosity=Heterozygous (Cosmic-CLP=909726; DepMap=ACH-000810). CC Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Homozygous (PubMed=9598804; Cosmic-CLP=909726; DepMap=ACH-000810). CC Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=10766161; PubMed=15009714; PubMed=21725359; PubMed=24576830; Cosmic-CLP=909726; DepMap=ACH-000810). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr284Argfs*21 (c.851_852delCA) (p.R283fs, c.849_850del2); Zygosity=Heterozygous (Cosmic-CLP=909726; DepMap=ACH-000810). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Expression; Large antibody panel staining analysis. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0%; East Asian, North=1.6%; East Asian, South=0%; South Asian=0%; European, North=62.41%; European, South=35.99% (PubMed=30894373). ST Source(s): Cosmic-CLP=909726; DSMZ=ACC-151; PubMed=25877200 ST Amelogenin: X,Y ST CSF1PO: 10 ST D13S317: 8,11 ST D16S539: 8,11 ST D18S51: 12,14 (DSMZ=ACC-151) ST D18S51: 13,15 (PubMed=25877200) ST D19S433: 14,15 ST D21S11: 29,31.2 ST D2S1338: 19,21 ST D3S1358: 15,16 ST D5S818: 9,12 ST D7S820: 8,9 ST D8S1179: 8,14 ST FGA: 20,21 ST Penta D: 12 ST Penta E: 5,14 ST TH01: 6 ST TPOX: 8,11 ST vWA: 15,17 DI NCIt; C3510; Cutaneous melanoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 67Y CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 47 // RX PubMed=11668190; DOI=10.1177/002215540104901105; RA Quentmeier, Hilmar RA Osborn, Mary RA Reinhardt, Julia RA Zaborski, Margarete RA Drexler, Hans Gunther RT "Immunocytochemical analysis of cell lines derived from solid RT tumors."; RL J. Histochem. Cytochem. 49:1369-1378(2001). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=7175440; DOI=10.1084/jem.156.6.1755; PMCID=PMC2186870; RA Houghton, Alan N. RA Eisinger, Magdalena RA Albino, Anthony P. RA Cairncross, J. Gregory RA Old, Lloyd John RT "Surface antigens of melanocytes and melanomas. Markers of melanocyte RT differentiation and melanoma subsets."; RL J. Exp. Med. 156:1755-1766(1982). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=24576830; DOI=10.1158/0008-5472.CAN-13-2625; PMCID=PMC4005042; RA Nissan, Moriah Heller RA Pratilas, Christine A. RA Jones, Alexis M. RA Ramirez, Ricardo RA Won, Helen RA Liu, Cai-Lian RA Tiwari, Shakuntala RA Kong, Li RA Hanrahan, Aphrothiti J. RA Yao, Zhan RA Merghoub, Taha RA Ribas, Antoni RA Chapman, Paul B. RA Yaeger, Rona D. RA Taylor, Barry Stephen RA Schultz, Nikolaus RA Berger, Michael F. RA Rosen, Neal RA Solit, David B. RT "Loss of NF1 in cutaneous melanoma is associated with RAS activation RT and MEK dependence."; RL Cancer Res. 74:2340-2350(2014). // RX PubMed=978138; DOI=10.1084/jem.144.4.873; PMCID=PMC2190439; RA Shiku, Hiroshi RA Takahashi, Toshitada RA Oettgen, Herbert Friedrich RA Old, Lloyd John RT "Cell surface antigens of human malignant melanoma. II. Serological RT typing with immune adherence assays and definition of two new surface RT antigens."; RL J. Exp. Med. 144:873-881(1976). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=6864164; DOI=10.1084/jem.158.1.53; PMCID=PMC2187084; RA Houghton, Alan N. RA Brooks, Hannah RA Cote, Richard J. RA Taormina, Michael C. RA Oettgen, Herbert Friedrich RA Old, Lloyd John RT "Detection of cell surface and intracellular antigens by human RT monoclonal antibodies. Hybrid cell lines derived from lymphocytes of RT patients with malignant melanoma."; RL J. Exp. Med. 158:53-65(1983). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=3473501; DOI=10.1073/pnas.84.12.4200; PMCID=PMC305052; RA Welt, Sydney RA Mattes, Michael Jules RA Grando, Roberto RA Thomson, Timothy M. RA Leonard, R.W. RA Zanzonico, Pat B. RA Bigler, Rodney Errol RA Yeh, Samuel D.J. RA Oettgen, Herbert Friedrich RA Old, Lloyd John RT "Monoclonal antibody to an intracellular antigen images human melanoma RT transplants in nu/nu mice."; RL Proc. Natl. Acad. Sci. U.S.A. 84:4200-4204(1987). // RX DOI=10.1007/978-1-4615-7228-2_39; RA Houghton, Alan N. RA Oettgen, Herbert Friedrich RA Old, Lloyd John RT "Malignant melanoma. Current status of the search for melanoma-specific RT antigens."; RL (In book chapter) Immunodermatology. Comprehensive Immunology, Vol 7; Safai, Bijan & Good, Robert Alan (eds.); pp.557-576; Springer; Boston; USA (1981). // RX PubMed=6933476; DOI=10.1073/pnas.77.7.4260; PMCID=PMC349812; RA Houghton, Alan N. RA Taormina, Michael C. RA Ikeda, Hisami RA Watanabe, Tadashi RA Oettgen, Herbert Friedrich RA Old, Lloyd John RT "Serological survey of normal humans for natural antibody to cell RT surface antigens of melanoma."; RL Proc. Natl. Acad. Sci. U.S.A. 77:4260-4264(1980). // RX PubMed=7509835; DOI=10.1111/1523-1747.ep12371784; RA Bouchard, Brigitte RA Vijayasaradhi, Setaluri RA Houghton, Alan N. RT "Production and characterization of antibodies against human RT tyrosinase."; RL J. Invest. Dermatol. 102:291-295(1994). // RX PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254; RA Nusinow, David Paul RA Szpyt, John RA Ghandi, Mahmoud RA Rose, Christopher M. RA McDonald, E. Robert 3rd RA Kalocsay, Marian RA Jane-Valbuena, Judit RA Gelfand, Ellen T. RA Schweppe, Devin Karl RA Jedrychowski, Mark P. RA Golji, Javad RA Porter, Dale A. RA Rejtar, Tomas RA Wang, Y. Karen RA Kryukov, Gregory V. RA Stegmeier, Frank RA Erickson, Brian K. RA Garraway, Levi Alexander RA Sellers, William Raj RA Gygi, Steven P. RT "Quantitative proteomics of the Cancer Cell Line Encyclopedia."; RL Cell 180:387-402.e16(2020). // RX PubMed=1716514; RA Albino, Anthony P. RA Davis, Brigid M. RA Nanus, David Michael RT "Induction of growth factor RNA expression in human malignant RT melanoma: markers of transformation."; RL Cancer Res. 51:4815-4820(1991). // RX PubMed=3081645; DOI=10.4049/jimmunol.136.7.2534; RA Panneerselvam, Mounanandham RA Welt, Sydney RA Old, Lloyd John RA Vogel, Carl-Wilhelm RT "A molecular mechanism of complement resistance of human melanoma RT cells."; RL J. Immunol. 136:2534-2541(1986). // RX PubMed=21725359; DOI=10.1038/onc.2011.250; PMCID=PMC3267014; RA Xing, Feng RA Persaud, Yogindra RA Pratilas, Christine A. RA Taylor, Barry Stephen RA Janakiraman, Manickam RA She, Qing-Bai RA Gallardo, Humilidad F. RA Liu, Cai-Lian RA Merghoub, Taha RA Hefter, Blake E. RA Dolgalev, Igor RA Viale, Agnes J. RA Heguy, Adriana RA de Stanchina, Elisa RA Cobrinik, David RA Bollag, Gideon RA Wolchok, Jedd David RA Houghton, Alan N. RA Solit, David B. RT "Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF RT dependence in melanomas harboring (V600E)BRAF."; RL Oncogene 31:446-457(2012). // RX PubMed=10766161; RA Tsao, Hensin RA Zhang, Xue RA Fowlkes, Kianna RA Haluska, Frank G. RT "Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous RT melanoma cell lines."; RL Cancer Res. 60:1800-1804(2000). // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). // RX PubMed=16957166; DOI=10.1369/jhc.6A7001.2006; PMCID=PMC3958123; RA Andersson, Ann-Catrin RA Stromberg, Sara RA Backvall, Helena RA Kampf, Caroline RA Uhlen, Mathias RA Wester, Kenneth RA Ponten, Fredrik RT "Analysis of protein expression in cell microarrays: a tool for RT antibody-based proteomics."; RL J. Histochem. Cytochem. 54:1413-1423(2006). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=15009714; DOI=10.1046/j.0022-202X.2004.22243.x; PMCID=PMC2586668; RA Tsao, Hensin RA Goel, Vikas RA Wu, Heng RA Yang, Guang RA Haluska, Frank G. RT "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 RT inactivation in melanoma."; RL J. Invest. Dermatol. 122:337-341(2004). // RX PubMed=3518877; DOI=10.3109/07357908609038260; RA Fogh, Jorgen RT "Human tumor lines for cancer research."; RL Cancer Invest. 4:157-184(1986). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=1067619; DOI=10.1073/pnas.73.9.3278; PMCID=PMC431008; RA Carey, Thomas E. RA Takahashi, Toshitada RA Resnick-Silverman, Lois A. RA Oettgen, Herbert Friedrich RA Old, Lloyd John RT "Cell surface antigens of human malignant melanoma: mixed RT hemadsorption assays for humoral immunity to cultured autologous RT melanoma cells."; RL Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144; RA Uphoff, Cord C. RA Pommerenke, Claudia RA Denkmann, Sabine A. RA Drexler, Hans Gunther RT "Screening human cell lines for viral infections applying RNA-Seq data RT analysis."; RL PLoS ONE 14:e0210404.1-e0210404.22(2019). // RX PubMed=9598804; DOI=10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; RA Walker, Graeme J. RA Flores, Jose F. RA Glendening, J. Michael RA Lin, Amy Hsiu-Ti RA Markl, Isabel D.C. RA Fountain, Jane W. RT "Virtually 100% of melanoma cell lines harbor alterations at the DNA RT level within CDKN2A, CDKN2B, or one of their downstream targets."; RL Genes Chromosomes Cancer 22:157-163(1998). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). //